Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001209191-23-022657

Options or other derivatives

  • CFO, Interim CEO & President acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Giacobello Scott M. CFO, Interim CEO & President 2023-04-03 Grant or award · Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X04/doc4.xml…